ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses

Javad Ghassemi-Rad , Wasundara Fernando, Bruce E. Holbein, David W. Hoskin*

Adv Pharm Bull. 2023;13(2): 368-377. doi: 10.34172/apb.2023.040

PMCID: PMC10278213 PMID: 37342371

Article

PDF

Full Text

XML

Cited By:

Research Article

2. Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis

Mohammad Sadegh Hashemzadeh* , Hadi Esmaeili Gouvarchin Ghaleh, Mozafar Mohammadi, Yaser Yousefpoor, Ehsan Rezaei, Gholamhossein Alishiri

Adv Pharm Bull. 2024;14(2): 483-495. doi: 10.34172/apb.2024.037

PMCID: PMC11347727 PMID: 39206397

Article

PDF

Full Text

XML

Cited By:

Original Article

3. PI3K Signaling Pathway Inhibitor Affects Myeloma Cells in a Culture-Dependent Manner

Mehrnaz Janfada , Sadaf Vahdat* , Saeid Kaviani*

Adv Pharm Bull. 2025;15(2): 440-452. doi: 10.34172/apb.025.42774

Article

PDF

Suppl 1

XML

Cited By:

Review Article

4. M2 Macrophages-Based Immunotherapy: A New Therapeutic Approach in Liver Fibrosis

Wahyu Widowati* , Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Elham Rismani* , Massoud Vosough*

Adv Pharm Bull. 2025;15(2): 314-325. doi: 10.34172/apb.025.43855

Article

PDF

XML

Cited By: